“
TL;DR
The central conclusion is that overcoming biological barriers remains the key challenge for improving the clinical translation of these non-viral systems.
Life · 5 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The central conclusion is that overcoming biological barriers remains the key challenge for improving the clinical translation of these non-viral systems.
The review describes the fundamental requirements for carrier development, such as chemical structure, surface charge, and modifications to facilitate overcoming extracellular and intracellular barriers. It concludes that while the main barriers are well studied and targeting molecules have been identified, the insufficient efficacy of non-viral carriers due to these biological hurdles still limits their widespread clinical use. The review positions the field at a turning point where non-viral approaches are becoming more competitive with viral vectors due to improved transfection results, suggesting future work will focus on enhancing carrier properties and specificity.